Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G T McInnes

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Clinical Pharmacology and Therapeutics|March 1, 1980
Activity of sulfur-containing intermediate metabolites of spironolactoneG T McInnes, M J Asbury, J R Shelton, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 28, 1999
Is cancer related to hypertension or to its treatment?A F Lever, D J Hole, C R Gillis, et al.
British Journal of Clinical Pharmacology|March 1, 1980
The active constituent of spironolactone after acute administration in man [proceedings]G T McInnes, M J Asbury, J R Shelton, et al.
Clinical Pharmacology and Therapeutics|August 1, 1981
Bioassay of a new aldosterone antagonist and evaluation of a simple method of quantitative comparisonG T McInnes, J R Shelton, M J Asbury, et al.
Journal of Human Hypertension|February 20, 2004
Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IVB Williams, N R Poulter, M J Brown, et al.
Journal of Hypertension|June 14, 2001
Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study GroupA Zanchetti, L Hansson, B Dahlöf, et al.
British Journal of Clinical Pharmacology|March 1, 1982
Relative potency and structure activity relationships of aldosterone antagonists in healthy man: correlation with animal experienceG T McInnes, J R Shelton, L E Ramsay, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 28, 1999
Mortality amongst patients of the Glasgow Blood Pressure Clinic was high in the 1970s and 80s but has fallen since, why?A F Lever, D G Beevers, D J Hole, et al.
British Journal of Clinical Pharmacology|February 1, 1993
Effect of renal function on the pharmacokinetics and pharmacodynamics of trandolaprilE G Bevan, G T McInnes, J C Aldigier, et al.
Journal of Hypertension|April 9, 1998
Cancer risk of hypertensive patients taking calcium antagonistsD J Hole, C R Gillis, I R McCallum, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Clinical Pharmacology and Therapeutics|March 1, 1980
Activity of sulfur-containing intermediate metabolites of spironolactoneG T McInnes, M J Asbury, J R Shelton, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 28, 1999
Is cancer related to hypertension or to its treatment?A F Lever, D J Hole, C R Gillis, et al.
British Journal of Clinical Pharmacology|March 1, 1980
The active constituent of spironolactone after acute administration in man [proceedings]G T McInnes, M J Asbury, J R Shelton, et al.
Clinical Pharmacology and Therapeutics|August 1, 1981
Bioassay of a new aldosterone antagonist and evaluation of a simple method of quantitative comparisonG T McInnes, J R Shelton, M J Asbury, et al.
Journal of Human Hypertension|February 20, 2004
Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IVB Williams, N R Poulter, M J Brown, et al.
Journal of Hypertension|June 14, 2001
Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study GroupA Zanchetti, L Hansson, B Dahlöf, et al.
British Journal of Clinical Pharmacology|March 1, 1982
Relative potency and structure activity relationships of aldosterone antagonists in healthy man: correlation with animal experienceG T McInnes, J R Shelton, L E Ramsay, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 28, 1999
Mortality amongst patients of the Glasgow Blood Pressure Clinic was high in the 1970s and 80s but has fallen since, why?A F Lever, D G Beevers, D J Hole, et al.
British Journal of Clinical Pharmacology|February 1, 1993
Effect of renal function on the pharmacokinetics and pharmacodynamics of trandolaprilE G Bevan, G T McInnes, J C Aldigier, et al.
Journal of Hypertension|April 9, 1998
Cancer risk of hypertensive patients taking calcium antagonistsD J Hole, C R Gillis, I R McCallum, et al.
Pageof 12